T. Rowe Price Investment Management, Inc. Vera Therapeutics, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $166 Billion
- Q3 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 984,001 shares of VERA stock, worth $32.8 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
984,001Holding current value
$32.8 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding VERA
# of Institutions
185Shares Held
55.2MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$144 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$131 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$111 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$98.8 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$93.2 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $902M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...